What is B. Riley’s Estimate for Celsius FY2025 Earnings?

Celsius Holdings, Inc. (NASDAQ:CELHFree Report) – Investment analysts at B. Riley boosted their FY2025 earnings estimates for Celsius in a research note issued on Wednesday, November 6th. B. Riley analyst J. Van. Sinderen now anticipates that the company will post earnings per share of $0.79 for the year, up from their prior estimate of $0.71. B. Riley has a “Buy” rating and a $47.00 price target on the stock. The consensus estimate for Celsius’ current full-year earnings is $0.70 per share.

A number of other research firms also recently weighed in on CELH. Bank of America decreased their target price on shares of Celsius from $32.00 to $26.00 and set an “underperform” rating for the company in a research report on Thursday, September 5th. Jefferies Financial Group decreased their target price on shares of Celsius from $53.00 to $48.00 and set a “buy” rating for the company in a research report on Thursday, October 10th. Piper Sandler decreased their price objective on shares of Celsius from $50.00 to $47.00 and set an “overweight” rating for the company in a research report on Tuesday, September 24th. Stifel Nicolaus decreased their price objective on shares of Celsius from $51.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, November 7th. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $50.00 price objective on shares of Celsius in a research report on Tuesday, August 20th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $54.40.

Read Our Latest Research Report on Celsius

Celsius Trading Down 5.2 %

Celsius stock opened at $27.39 on Monday. The company has a market cap of $6.44 billion, a P/E ratio of 38.04, a price-to-earnings-growth ratio of 2.52 and a beta of 1.86. Celsius has a 1-year low of $27.37 and a 1-year high of $99.62. The company has a fifty day simple moving average of $32.15 and a 200 day simple moving average of $50.92.

Insiders Place Their Bets

In other Celsius news, CEO John Fieldly sold 74,847 shares of Celsius stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the sale, the chief executive officer now owns 1,812,490 shares in the company, valued at $59,449,672. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of Celsius

Several hedge funds and other institutional investors have recently bought and sold shares of CELH. Vanguard Group Inc. increased its holdings in Celsius by 18.7% in the 1st quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock valued at $1,352,737,000 after buying an additional 2,567,290 shares during the period. Capital International Investors increased its holdings in Celsius by 50.6% in the 1st quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock valued at $328,877,000 after buying an additional 1,333,217 shares during the period. Massachusetts Financial Services Co. MA increased its holdings in Celsius by 231.2% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock valued at $225,289,000 after buying an additional 2,754,722 shares during the period. Bank of New York Mellon Corp increased its holdings in Celsius by 36.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,942,433 shares of the company’s stock valued at $167,983,000 after buying an additional 790,014 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its holdings in Celsius by 0.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,802,264 shares of the company’s stock valued at $232,365,000 after buying an additional 9,054 shares during the period. Institutional investors and hedge funds own 60.95% of the company’s stock.

Celsius Company Profile

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Stories

Earnings History and Estimates for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.